XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Other Undenominated Capital
Accumulated Other Comprehensive Income
Retained Earnings
Redeemable Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2019   53,622,206          
Beginning balance at Dec. 31, 2019 $ 1,618,055 $ 4,635 $ 577,961 $ 1,052 $ (75,819) $ 1,110,226  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 332,331         332,331  
Currency translation adjustment 46,526       46,526    
Unrealized capital loss - investments (231)       (231)    
Actuarial gain (loss) on defined benefit pension plan (4,138)       (4,138)    
Amortization of cash flow hedge (910)       (910)    
Loss on cash flow hedge (905)       (905)    
Total comprehensive income attributable to the Group 372,673            
Exercise of share options (in shares)   193,417          
Exercise of share options 13,189 $ 13 13,176        
Issue of restricted share units / performance share units (in shares)   207,688          
Issue of restricted share units / performance share units 14 $ 14          
Share based compensation expense 25,981   25,981        
Share issue costs (14)   (14)        
Repurchase of ordinary shares (in shares)   (1,235,218)          
Repurchase of ordinary shares (175,000) $ (82)   82   (175,000)  
Share repurchase costs (140)         (140)  
Noncontrolling interest adjustment to redemption amount (4,522)         (4,522) $ 4,522
Ending balance (in shares) at Dec. 31, 2020   52,788,093          
Ending balance at Dec. 31, 2020 1,850,236 $ 4,580 617,104 1,134 (35,477) 1,262,895  
Beginning balance at Dec. 31, 2019             39,510
Increase (Decrease) in Temporary Equity [Roll Forward]              
Net income             633
Noncontrolling interest adjustment to redemption amount (4,522)         (4,522) 4,522
Exercise of call option on noncontrolling interest shares             (44,665)
Ending balance at Dec. 31, 2020             $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 153,185         153,185  
Currency translation adjustment (60,617)       (60,617)    
Unrealized capital loss - investments 0            
Actuarial gain (loss) on defined benefit pension plan 4,266       4,266    
Amortization of cash flow hedge 113       113    
Loss on cash flow hedge 778       778    
Total comprehensive income attributable to the Group 97,725            
Exercise of share options (in shares)   1,065,529          
Exercise of share options 118,589 $ 77 118,512        
Issue of restricted share units / performance share units (in shares)   328,634          
Issue of restricted share units / performance share units 23 $ 23          
Share based compensation expense 133,553   133,553        
Share issue costs (853)   (853)        
Issue of shares associated with a business combination (in shares)   27,372,427          
Issue of shares associated with a business combination 5,658,155 $ 1,960 5,656,195        
Replacement share-based awards issued to acquiree employees $ 209,399   209,399        
Ending balance (in shares) at Dec. 31, 2021 81,554,683 81,554,683          
Ending balance at Dec. 31, 2021 $ 8,066,827 $ 6,640 6,733,910 1,134 (90,937) 1,416,080  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 505,304         505,304  
Currency translation adjustment (89,530)       (89,530)    
Unrealized capital loss - investments 0            
Actuarial gain (loss) on defined benefit pension plan 12,657       12,657    
Amortization of cash flow hedge 0            
Loss on cash flow hedge (3,728)       (3,728)    
Total comprehensive income attributable to the Group 424,703            
Exercise of share options (in shares)   348,286          
Exercise of share options 35,828 $ 21 35,807        
Issue of restricted share units / performance share units (in shares)   241,116          
Issue of restricted share units / performance share units 16 $ 16          
Share based compensation expense 70,606   70,606        
Share issue costs (17)   (17)        
Repurchase of ordinary shares (in shares)   (420,530)          
Repurchase of ordinary shares (99,983) $ (28)   28   (99,983)  
Share repurchase costs $ (17)         (17)  
Ending balance (in shares) at Dec. 31, 2022 81,723,555 81,723,555          
Ending balance at Dec. 31, 2022 $ 8,497,963 $ 6,649 $ 6,840,306 $ 1,162 $ (171,538) $ 1,821,384